ci 934 has been researched along with oxolinic acid in 2 studies
| Studies (ci 934) | Trials (ci 934) | Recent Studies (post-2010) (ci 934) | Studies (oxolinic acid) | Trials (oxolinic acid) | Recent Studies (post-2010) (oxolinic acid) |
|---|---|---|---|---|---|
| 33 | 0 | 2 | 456 | 15 | 56 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domagala, JM; Heifetz, CL; Mich, TF; Nichols, JB | 1 |
| Amyes, SG; Barnes, AC; Hastings, TS; Lewin, CS | 1 |
2 other study(ies) available for ci 934 and oxolinic acid
| Article | Year |
|---|---|
1-Ethyl-7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4- dihydro-4-oxo-3-quinoline-carboxylic acid. New quinolone antibacterial with potent gram-positive activity.
Topics: Animals; Anti-Bacterial Agents; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Naphthyridines; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1986 |
In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.
Topics: Aeromonas; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Osmolar Concentration; Oxolinic Acid; Quinolones; Sodium Chloride | 1990 |